Changes in erythropoietin and vascular endothelial growth factor following the use of different altitude training concepts

J Sports Med Phys Fitness. 2020 May;60(5):677-684. doi: 10.23736/S0022-4707.20.10404-3.

Abstract

Background: Erythropoietin (EPO) and vascular endothelial growth factor (VEGF) are important factors regulating erythropoiesis and angiogenesis. Altitude/hypoxic training may induce elevated VEGF-A and EPO levels. However, it appears that the range of adaptive changes depends largely on the training method used. Therefore, we investigated the changes in EPO and VEGF-A levels in athletes using three different altitude/hypoxic training concepts.

Methods: Thirty-four male cyclists were randomly divided into four groups: LH-TL group ("live high-train low" protocol), HiHiLo ("live high - base train high - interval train low" procedure), IHT ("intermittent hypoxic training") and control group (CN, normoxic training). The same 4-week training program was used in all groups. Blood samples were taken before and after each training week in order to evaluate serum EPO and VEGF-A levels.

Results: In the LH-TL and HiHiLo groups, EPO increased (P<0.001) after 1st week and remained elevated until 3rd week of altitude training. In the IHT and CN groups, EPO did not change significantly. VEGF-A was higher (P<0.001) after 2nd and 3rd week of training in the IHT group. In the HiHiLo group, VEGF-A changed (P<0.05) only after 3rd week. No significant changes of VEGF-A were noted in the LH-TL and CN groups.

Conclusions: Altitude/hypoxic training is effective in increasing VEGF-A and EPO levels. However, a training method plays a key role in the pattern of adaptations. EPO level increase only when an adequate hypoxic dose is provided, whereas VEGF-A increases when the hypoxic exposure is combined with exercise, particularly at high intensity.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acclimatization / physiology*
  • Adult
  • Altitude
  • Erythropoietin / blood*
  • Exercise / physiology*
  • Humans
  • Hypoxia / blood
  • Male
  • Vascular Endothelial Growth Factor A / blood*
  • Young Adult

Substances

  • EPO protein, human
  • Vascular Endothelial Growth Factor A
  • Erythropoietin